Research Article
DRG prospective payment systems: refine or not refine?
Article first published online: 24 SEP 2009
DOI: 10.1002/hec.1547
Copyright © 2009 John Wiley & Sons, Ltd.
Additional Information
How to Cite
Hafsteinsdottir, E. J. G. and Siciliani, L. (2010), DRG prospective payment systems: refine or not refine?. Health Economics, 19: 1226–1239. doi: 10.1002/hec.1547
Publication History
- Issue published online: 9 SEP 2010
- Article first published online: 24 SEP 2009
- Manuscript Accepted: 17 JUL 2009
- Manuscript Revised: 1 JUN 2009
- Manuscript Received: 15 AUG 2008
- Abstract
- Article
- References
- Cited By
Keywords:
- hospitals;
- refinement;
- diagnosis-related groups
Abstract
We present a model of contracting between a purchaser of health services and a provider (a hospital). We assume that hospitals provide two alternative treatments for a given diagnosis: a less intensive one (for example, a medical treatment) and a more intensive one (a surgical treatment). We assume that prices are set equal to the average cost reported by the providers, as observed in many OECD countries (yardstick competition). The purchaser has two options: (1) to set one tariff based on the diagnosis only and (2) to differentiate the tariff between the surgical and the medical treatment (i.e. to refine the tariff). We show that when tariffs are refined, the provider has always an incentive to overprovide the surgical treatment. If the tariff is not refined, the hospital underprovides the surgical treatment (and overprovides the medical treatment) if the degree of altruism is sufficiently low compared with the opportunity cost of public funds. Our main result is that price refinement might not be optimal. Copyright © 2009 John Wiley & Sons, Ltd.

1099-1050/asset/HEC_centre.gif?v=1&s=0185bf508eda50f535786bfd8e22b47c50d0e4db)
